Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Danggui Buxue Decoction is a Traditional Chinese Medicine (TCM) herbal formulation being evaluated for the treatment of knee osteoarthritis and degenerative bone and joint diseases. It is a variation of the classic Danggui Buxue Decoction, which is traditionally composed of *Astragalus membranaceus* (Huangqi) and *Angelica sinensis* (Danggui) in a 5:1 ratio. The modification involves the addition of other medicinal herbs to specifically target joint pain, inflammation, and bone health. The decoction is being studied by the Gansu Provincial Hospital of Traditional Chinese Medicine as part of a clinical research program to establish evidence-based guidelines for TCM in orthopedics. It is typically administered orally as a liquid extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Danggui Buxue Decoction.